|
2024
|
Invention
|
Selective phd1 inhibitor compounds, compositions, and methods of use.
The present invention prov... |
|
|
Invention
|
Picolinamide compounds as selective phd1 inhibitors, compositions, and methods of use.
The prese... |
|
|
G/S
|
Pharmaceutical products and preparations for the treatment
of anemia; pharmaceuticals for the tr... |
|
|
G/S
|
Pharmaceutical products and preparations for the treatment of anemia; pharmaceuticals for the tre... |
|
2023
|
Invention
|
Prolyl hydroxylase inhibitors and methods of use.
The present disclosure relates to HIF-la proly... |
|
|
Invention
|
Compositions and methods for treating anemia.
Provided herein are specific doses of, and dosing ... |
|
|
G/S
|
pharmaceutical products and preparations for the treatment of anemia; pharmaceuticals for the tre... |
|
|
Invention
|
Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl] amino] acetic acid. Di... |
|
|
Invention
|
Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions,... |
|
2022
|
Invention
|
Picolinamide compounds as selective phd1 inhibitors, compositions, and methods of use. The presen... |
|
|
Invention
|
Selective phd1 inhibitor compounds, compositions, and methods of use. The present invention provi... |
|
|
Invention
|
Methods for treating viral infections, organ injury, and related conditions.
Disclosed herein ar... |
|
|
Invention
|
Prolyl hydroxylase inhibitors and methods of use. The present disclosure relates to HIF-1α prolyl... |
|
|
Invention
|
Compositions and methods for treating anemia. Provided herein are specific doses of, and dosing r... |
|
|
Invention
|
Modulation of drug-drug interactions of vadadustat.
Provided herein are methods for reducing, mi... |
|
|
Invention
|
Modulation of drug-drug interactions of vadadustat. Provided herein are methods for reducing, min... |
|
|
Invention
|
Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amides.
Di... |
|
|
Invention
|
Therapeutic methods using vadadustat.
This invention provides methods for the treatment of anemi... |
|
|
Invention
|
Therapeutic methods using vadadustat. This invention provides methods for the treatment of anemia... |
|
|
Invention
|
Compounds and composition for the treatment of anemia. Provided herein are therapeutic methods co... |
|
2021
|
Invention
|
Phd inhibitor compounds, compositions, and methods of use. The present invention provides, in par... |
|
|
Invention
|
Manufacturing process for 3,5-dichloropicolinonitrile for synthesis of vadadustat.
Disclosed her... |
|
|
Invention
|
Manufacturing process for 3,5-dichloropicolinonitrile for synthesis of vadadustat. Disclosed here... |
|
|
Invention
|
Treatment of viral infections, of organ injury, and of related conditions using a hif prolyl hydr... |
|
|
Invention
|
Phd inhibitor compounds, compositions, and use.
The present invention provides, in part, novel s... |
|
|
Invention
|
Phd inhibitor compounds, compositions, and their use.
The present invention provides, in part, n... |
|
|
Invention
|
Phd inhibitor compounds, compositions, and use. e.ge.g.(e.g.(e.g.(e.g. acute kidney injury and ch... |
|
|
Invention
|
Phd inhibitor compounds, compositions, and their use. The present invention provides, in part, no... |
|
|
Invention
|
Phd inhibitor compounds, compositions, and use. The present invention provides, in part, novel sm... |
|
|
Invention
|
Phd inhibitor compounds, compositions, and use. e.ge.ge.ge.ge.g. acute kidney injury and chronic ... |
|
2020
|
Invention
|
Method for producing nitrogen-containing heteroarylcarboxamide acetic acid derivative.
The prese... |
|
|
Invention
|
Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid. Provided her... |
|
|
Invention
|
Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amides. Dis... |
|
2019
|
Invention
|
Benzimidazole derivative for use in the treatment of inflammatory disorders. Provided herein are ... |
|
|
Invention
|
Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid. Disc... |
|
|
G/S
|
Providing patients who have been prescribed a course of therapy that involves prescription pharma... |
|
|
Invention
|
Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amides. Di... |
|
2018
|
G/S
|
Pharmaceutical preparations for the treatment of hematological, oncological, cardiovascular, diab... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of hematological, oncological, immunological, cardi... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of
hematological, oncological, immunological, card... |
|
2017
|
G/S
|
Pharmaceutical preparations for the treatment of hematological conditions and diseases, and pharm... |
|
2015
|
G/S
|
Pharmaceutical preparations for the treatment of blood disorders, oncological, immunologic diseas... |
